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Wednesday, February 11, 2015 583amonitor and regulate intracellular calcium and are ideal pharmacological
targets for immunosuppression, fibroproliferative disorders, hypertension and
various neurological diseases. However, the development of drugs specifically
for these medically relevant channels faces serious challenges because there is
no available crystal structure that could be used for structure-assisted drug
design. We used the Kv1.2-Kv2.1 channel structure (pdb id: 2R9R) as a tem-
plate to generate a homology model of the KCa3.1 channel transmembrane
region using the Rosetta modeling method. Docking of small molecules that
are known to block KCa3.1 channel currents using Rosetta generated structural
models of channel - drug complexes that can be validated using experimental
approaches. Here we report the validation of the binding sites for the dihydro-
pyridine nifedipine predicted by Rosetta’s lowest energy stimulation of the
KCa3.1 channel complex. We used a combination of site-directed mutagenesis
and electrophysiological patch-clamp recording to test the identified amino
acid residues located between the pore lining S5 and S6 segment. Blocking
of the KCa3.1 channel by nifedipine was reduced by altering the side chains
at positions L209, T212 and V278 to either alanine or valine, with T212 the
most affected residue. Bulkier side-chain change to phenylalanine confirmed
T212 as the main interacting site for nifedipine without compromising the
channel’s affinity for TRAM-34. Thus, by correctly identified the interaction
of the dihydropyridine nifedipine with the KCa3.1 channel complex, Rosetta
models can be used to understand the molecular mechanism of action of
KCa channel blockers and gating modulators and assist with drug design
efforts.
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GBR-12909 (vanoxerine) is a potent highly selective dopamine transporter
antagonist. It was initially developed for treatment of Parkinson’s disease
and while safe in man, lacked efficacy. Although a potent hERG blocker,
the drug exhibits multiple ion channel effects including frequency-
dependence. The drug effectively terminated induced, sustained atrial fibril-
lation (AF) and atrial flutter in a canine model of sterile pericarditis.
Subsequently the drug terminated AF in a Phase 2B ascending dose trial. Pre-
vious in vitro measurements used protocols that did not address the issue of the
late Nav1.5 current which is important in understanding safety of a potent
hERG blocker.
Peak and late sodium currents were measured in HEK-293 cells stably ex-
pressing the human Nav1.5 channel. Peak currents were measured using a
step-ramp protocol consisting of a 40 ms step to 15 mV (where the peak
current was measured), a 180 ms step to þ30 mV and a 200 ms ramp to
the holding potential of 80 mV (1 Hz stimulating frequency). The effect
of the drug was parameterized with a single binding isotherm having an
IC50 of 29 5 3 nM (95% CI: 22-37) and a Hill coefficient of 0.91 5 0.10
(95% CI: 0.68-1.18) (seven cells, three concentrations). We also evaluated
the effect of GBR-19209 on currents increased using the sea-anemone toxin
ATX-II as a surrogate of the late sodium current. The calculated IC50 and
Hill coefficients from five cells and five concentrations were 93 5 9 nM
(95% CI: 7-117) and 1.57 5 0.24 (95% CI: 1.05-2.67), respectively. Thus,
GBR-12909 block is at least sixty times more potent than ranolazine’s
(IC50 ¼ 6 mM).The combination of potent peak and late sodium block may
explain the antiarrhythmic and safe profile of the drug.
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Understanding how small molecules potentiate CFTR gating is critical for
developing novel therapy for cystic fibrosis. Our previous studies have sug-
gested that VX-770 (ivacaftor), a CFTR potentiator now used in clinics,
increases the Po of CFTR by shifting the gating conformational changes in
CFTR’s transmembrane domains (TMDs) to favor the open channel configura-
tion. Lately, another CFTR potentiator NPPB was reported to enhance CFTR
activity through a modus operandi that exploits the ATP hydrolysis-driven,
non-equilibrium gating mechanism unique to CFTR. It is however puzzling
that NPPB can also increase the activity of non-hydrolytic G551D-CFTR,
the third most common pathogenic mutation. We therefore set forth to unravel
the mechanism of NPPB using VX-770 as a reference. Once the blocking effect
of NPPB was corrected, we found that NPPB and VX-770, when applied alone,
increased the Po of G551D-CFTR by 6.95 0.8 (n ¼ 12) and 9.35 1.4 (n ¼21) folds respectively. Once these two reagents were applied together, how-
ever, the Po was increased by 28.985 7.6 fold (n¼ 10), less than the expected
magnitude (~ 60-fold) if NPPB and VX-770 work independently. Hence, NPPB
only increases the Po of G551D-CFTR by 3.75 0.4 fold (n ¼ 9) in the pres-
ence of VX-770. Similarly, a much reduced enhancement (4.85 1.8 fold, n ¼
5) of the Po by VX-770 in the presence of NPPB was seen. Interestingly, we
also observed that VX-770 effectively potentiates a CFTR mutant with its sec-
ond nucleotide-binding domain completely removed (i.e., dNBD2), whereas
NPPB has virtually no effect (n ¼ 12). These results can be explained by a
gating model featuring an energetic coupling between opening/closing of the
gate in TMDs where VX-770 binds and dimerization/dissociation of NBDs
where NPPB acts on.
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‘‘Use-’’ or ‘‘state-’’ dependent block of voltage-gated sodium channels is
characteristic of therapeutic agents used to moderate electrical activity in path-
ologically hyperactive tissues and combat certain forms of epilepsy, cardiac
arrhythmia, myotonia, and pain. Externally acting Na channel pore blockers
are not commonly used as therapeutic drugs, but intraperitoneal m-conotoxin
(mCTX) KIIIA can act as an effective analgesic against inflammatory pain in
mice, at concentrations that do not cause obvious systemic side effects (Zhang
et al 2007 J Biol Chem 42:30699). This action appears to result from highly
specific targeting to neuronal Na channels, without essential reliance on the
use-dependent potency that contributes to the efficacy of clinical local anes-
thetics. mCTXs, although highly selective among closely related eukaryotic
Na channels, have recently been found to block bacterial Nav channels with
high affinity (Chen & Chung 2012 Biophys J 102:483; Finol-Urdaneta et al
2013 Biophys J 104:136a). In addition, the block was potentiated at more de-
polarized holding potentials. Here, we explore the dependence of mCTX PIIIA
block of NaChBac and NavSp1 on varying patterns of conditioning depolari-
zation. Briefly, in the low picomolar range, PIIIA application was associated
with faster inactivation decay during a test depolarization, and block of the
peak current. The speeding of inactivation precedes the block of current
following PIIIA application, and this kinetic effect was obvious at more nega-
tive holding potentials than was the decrease in peak current. In NaChBac, both
activation and inactivation were shifted in the hyperpolarizing direction by
~25-30 mV in the presence of 5pM PIIIA. The data suggest that PIIIA binding
is conformation dependent, with high affinity for non-conducting, depolariza-
tion-induced states. At present, the relative importance of ‘‘pre-activated’’
and ‘‘in-activated’’ states in potentiating inhibition by PIIIA is unclear.
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Sodium absorption in epithelial cells is rate-limited by the epithelial sodium
channel (ENaC) activity in lungs, kidney and the distal colon. Pathophysiolog-
ical conditions, such as cystic fibrosis and Liddle syndrome, result from water-
electrolyte imbalance partly due to malfunction of ENaC’s molecular regu-
lation. The molecular mechanism(s) of pathologically implicated mutations
in ENaC subunits are largely unknown due to absence of structural models
for ENaC’s oligomers. Here, we propose a dynamics-driven mechanism of
the gain of function mutation aW493R implicated in atypical cystic fibrosis.
We utilize a combination of discrete molecular dynamics simulations (DMD)
of the extracellular region of ENaC’s heterotrimer abg and functional data
from whole-cell electrophysiology experiments. Structure-function studies
suggest that tetramers and trimers are the major characterized functional olig-
omeric states of ENaC. Using the crystal structure of the acid sensing ion chan-
nel, ENaC’s structural homolog in the ENaC/degenerin mechanosensitive
ion channel family, we have constructed homology models of ENaC subunits
alpha, beta and gamma, in addition to the heterotrimers abg, agb and the
heterotetramer abag. Electrophysiology data show constitutive activity of
aW493Rbg in oocytes indicated by higher open probability and elevated basal
activity compared to WT. Our DMD simulation provides an allosteric frame-
work, which agrees with experimental data. W493R rewires the electrostati-
cally mediated inter-residue interaction network in close proximity to W493,
resulting in widening of the pore geometry in the outer mouth of the pore in
584a Wednesday, February 11, 2015the extracellular region. Rewiring effect of inter-residue interactions in 493R
mutant pocket allosterically propagates across the channel resulting in a
more stabilized global conformational ensemble of the channel. These findings
predict a novel mechanism of ENaC’s constitutive activity, in which changes
in local dynamics can affect the relative population of the channel’s active
states and its open probability.
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As a member of the ATP-binding cassette (ABC) protein superfamily, CFTR, a
phosphorylation-activated but ATP-gated chloride channel, is comprised of
two transmembrane domains (TMDs) that form a gated anion conducting
pore and two nucleotide binding domains (NBDs) whose dimerization/dissoci-
ation is allosterically coupled to opening/closing of the gate. Recent cysteine
scanning of CFTR’s TMDs not only identified pore-lining residues, but also
suggested molecular motions of the TMDs involved in opening/closing
of the ‘‘gate’’. Since many of the pore-lining residues exhibit clear state-
dependent exposure to the aqueous pore, it is predicted that mutations at these
positions might affect gating by altering the free energy level of a particular
state. T338 was chosen because this pore-lining residue is mostly concealed
from the pore in the closed state. We converted T338 to various amino acids
and found that the physical properties of the side-chain at this position indeed
affect CFTR gating as well as anion conductance. For hydrophilic residues like
threonine itself (0.575 0.06, n ¼ 4), serine (0.455 0.02, n ¼ 12) and aspar-
agine (0.88 5 0.02, n ¼ 6), the larger the side-chain, the higher the Po. In
contrast, for hydrophobic ones such as alanine (0.605 0.02, n ¼ 6), isoleucine
(0.195 0.03, n¼ 6) and valine (0.445 0.05, n ¼ 7), the larger the side-chain,
the lower the Po. Single-channel kinetic analysis revealed that mutations
mainly affect the open time. To exclude possible effects of the mutation on
ATP hydrolysis, we introduced some mutations into the E1371S background,
whose ATP hydrolysis is abolished. Interestingly, mutations that shorten the
open time under the wild-type background also decrease significantly the Po
in E1371S. The implications of our data on the gating and permeation mecha-
nisms for CFTR will be discussed.
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Introduction: The cardiac Naþ/Ca2þ exchanger 1 (NCX1) modulates
excitation-contraction coupling and contributes to Ca2þ removal in cardiomyo-
cytes. Altered expression and activity of NCX1 is linked to dysfunctional Ca2þ
handling in chronic heart disease. Consequently, modulation of NCX1 activity
is proposed as a therapeutic target. The cytosolic loop of NCX1, ~550 amino
acids, comprises several important docking and regulation sites. In particular,
phospholemman (PLM) has been shown to interact and inhibit NCX1 activity
when phosphorylated at serine 68 (pSer68-PLM). Importantly, pSer68-PLM
has been shown as a substrate for protein phosphatase 1 (PP1) in the context
of PLM regulation of the sodium-potassium pump. PP1 regulation of NCX1
is unknown.
Hypothesis: PP1 binds to NCX1 and regulates its activity by dephosphorylat-
ing pSer68-PLM.
Methods and Results: Using co-immunoprecipitation in rat heart lysates we
have shown that NCX1 exists in a macromolecular complex with PP1 and
PLM. This facilitates specific control of NCX function. Bioinformatic analysis
revealed three putative PP1 binding sites on NCX1. Co-localization studies,
co-immunoprecipitations, pull down, mutation- and peptide overlay assays
indicated that PP1 bound directly to the consensus sequence R/KVxF in cal-
cium binding domain 1 (CBD1) of NCX1. The reciprocal NCX1 binding site
in PP1 was identified within residues 235-260, a region which harbours
important anchoring sites. A peptide docking model was generated showing
how the R/KVxF peptide may bind in the hydrophobic pocket of PP1. Surface
plasmon resonance analysis indicated that the NCX1-PP1 binding is strong
and stable. This binding does not inhibit PP1 activity. Co-expression of
NCX1 with PLM and PP1 in HEK293 down regulates pSer68-PLM, indi-cating that PP1-R/KVxF- binding is a prerequisite for dephosphorylation of
pSer68-PLM.
Conclusion: R/KVxF motif in NCX1-CBD1 anchors PP1, does not change the
activity of the enzyme and facilitates dephosphorylation of pSer68-PLM.
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The pore-domain of TRPA1 mediates the inhibitory effect of the antagonist
6-Methyl-5-(2-(trifluoromethyl)phenyl)-1H-indazole
The ion channel TRPA1 gives to the organisms the ability to detect noxious
chemicals to sensory neurons and as a result of this, mediates chemical nocicep-
tion in vivo. Mouse TRPA1 is activated by electrophilic compounds such as
mustard-oil (MO) and several physical stimuli such as cold temperature.
Both stimuli are mechanistic linked to the N terminus of the channel. Due to
its sensory function, the inhibition of TRPA1 activity might provide an effec-
tive treatment against chronic and inflammatory pain, for that reason, TRPA1
has become an important target for the development of new and better analgesic
drugs. 6-Methyl-5-(2-(trifluoromethyl)phenyl)-1H-indazole (Compound 31)
has been identified by a chemical screen and lead optimization as an inhibitor
of chemical activation of TRPA1. However, the structures or domains of
TRPA1 that mediate the inhibitory effect of Compound 31 are unknown.
Here, we screened 12,000 random mutant clones of mouse TRPA1 for their
sensitivity to mustard-oil and the ability of Compound 31 to inhibit chemical
activation by MO. We identified five mutations located within the pore domain
that cause loss of inhibition by Compound 31, one of them in the residue T877
placed in the TM5, important in the binding of menthol, a dose-dependent
agonist/blocker. This result demonstrates that the pore-domain is a regulator
of chemical activation and suggests that Compound 31 might be acting directly
on the pore-domain.
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Response to mechanical stimuli, which includes proper development of biolog-
ical tissues and organs, is essential to the cell. Mechanosensitive ion channels
are the basic elements among mechanosensing molecules and complexes.
Although the traditional patch clamp technique using glass micropipettes is
still widely used for electrophysiology, it is difficult to control the mechanical
stimulus to ion channels in this system. Here we developed a novel patch clamp
system with a planar stretchable electrode to record mechanosensitive re-
sponses of ion channels. Planar electrodes of 100 mm thickness were fabricated
using silicone resin. Next, we prepared HEK293 cells transfected with the
stretch-activated KCa (SAKCA) channel, which is mechanosensitive, for
planar patch clamp recordings. Using our planar patch clamp system, a giga-
ohm seal was achieved with a maximum seal resistance of 10 GU. The success
rate of gigaohm seal formation was 37%. Then we recorded single channel
currents with a slope conductance of 285.4 pS, which is parallel to the known
SAKCA current. Using scanning electron microscope, we confirmed elonga-
tion of the aperture by 37.7% when 50% stretch was applied to the planar
electrode. It is expected that a controllable and sufficient stretch stimulus can
be applied to the cellular membrane using our newly developed planar patch
clamp system.
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The Long QT Syndrome (LQTS) is characterized by a prolongation of the QT
interval on an ECG and occurrences of ventricular fibrillation, polymorphic
ventricular tachycardia, and sudden cardiac death. In patients with LQTS
variant 3 (LQT3), mutations in the cardiac sodium channel alpha subunit,
Nav1.5, disrupt channel inactivation by multiple mechanisms and can cause
a sustained depolarizing current (INaL) sufficient to prolong the ventricular
action potential. LQT3 mutant sodium channels are therefore a reliable exper-
imental model for the study of the function and pharmacology of dysfunctional
